European Medical Solutions (STU:AS00) Valuation Rank


STU:AS00 European Medical Solutions STU:AS00
50 GF Score
Price €4.80
GF Value €8.11
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


European Medical Solutions Valuation Rank Related Terms

STU:AS00
50GF Score
European Medical Solutions STU:AS00
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.80 is trading 40.8% below its estimated GF Value™ of €8.11.

Key valuation signals for STU:AS00:

  • Valuation Rank:
  • GF Value™: €8.11 vs. price of €4.80 (40.8% below fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
50GF Score

Get the complete analysis for STU:AS00

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.80
Price
€8.11
GF Value